Antibody drug conjugates (ADCs) are biotherapeutics, composed of small molecule drugs conjugated to an antibody scaffold, that have very complex molecular structures. The information about the average ...
A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models. The final day of education at Asembia’s AXS25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
